Pfizer’s Paxlovid Reconsidered For Lower-Risk COVID Patients
Doctors are having second thoughts about using Pfizer Inc’s COVID-19 antiviral pill Paxlovid in lower risk patients. Their reconsideration comes after a US Public Health Agency issued a warning about…